カテゴリー： LP Information, 世界, 医療/バイオ

先進的非経口薬物送達装置のグローバル市場予測2023-2029

◆英語タイトル：Global Advanced Parenteral Drug Delivery Devices Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23MY4003）◆商品コード：LP23MY4003
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月（※2025年版があります。お問い合わせください。）
◆ページ数：108
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥527,040見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥790,560見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,054,080見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LP Informationの最新刊調査レポート「先進的非経口薬物送達装置のグローバル市場」は、過去の販売実績から2022年の世界の先進的非経口薬物送達装置の総販売量を検討し、2023年から2029年の予測される先進的非経口薬物送達装置の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の先進的非経口薬物送達装置の市場規模を掲載し、XXX百万米ドル規模の世界の先進的非経口薬物送達装置市場の詳細な分析を提供します。本インサイトレポートは、世界の先進的非経口薬物送達装置業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の先進的非経口薬物送達装置市場における各社の独自のポジションをより深く理解するために、先進的非経口薬物送達装置製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の先進的非経口薬物送達装置市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。先進的非経口薬物送達装置の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。先進的非経口薬物送達装置の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。先進的非経口薬物送達装置のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

先進的非経口薬物送達装置の世界主要メーカーとしては、Abbott Laboratories、 Amgen、 Pfizer、 Roche、 AstraZeneca、 BD、 Boston Scientific、 Bristol-Myers Squibb、 GSK、 Novartisなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の先進的非経口薬物送達装置市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場セグメンテーション】

この調査では先進的非経口薬物送達装置市場をセグメンテーションし、種類別 (プレフィルシリンジ、IVカテーテル、バイアルバッグ注入装置、皮下シリンジ、その他)、用途別 (病院、診療所、ASC、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：プレフィルシリンジ、IVカテーテル、バイアルバッグ注入装置、皮下シリンジ、その他

・用途別区分：病院、診療所、ASC、その他

・地域別区分
南北アメリカ（米国、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の先進的非経口薬物送達装置市場の10年間の市場状況・展望は？
・世界および地域別に見た先進的非経口薬物送達装置市場成長の要因は何か？
・先進的非経口薬物送達装置の市場機会はエンドマーケットの規模によってどのように変化するのか？
・先進的非経口薬物送達装置のタイプ別、用途別の内訳は？
・新型コロナウイルスとロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：先進的非経口薬物送達装置の年間販売量2018-2029、地域別現状・将来分析
・先進的非経口薬物送達装置の種類別セグメント：プレフィルシリンジ、IVカテーテル、バイアルバッグ注入装置、皮下シリンジ、その他
・先進的非経口薬物送達装置の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・先進的非経口薬物送達装置の用途別セグメント：病院、診療所、ASC、その他
・先進的非経口薬物送達装置の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の先進的非経口薬物送達装置市場
・企業別のグローバル先進的非経口薬物送達装置市場データ：2018-2023年の年間販売量、市場シェア
・企業別の先進的非経口薬物送達装置の年間売上：2018-2023年の売上、市場シェア
・企業別の先進的非経口薬物送達装置販売価格
・主要企業の先進的非経口薬物送達装置生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

先進的非経口薬物送達装置の地域別レビュー
・地域別の先進的非経口薬物送達装置市場規模2018-2023：年間販売量、売上
・主要国別の先進的非経口薬物送達装置市場規模2018-2023：年間販売量、売上
・南北アメリカの先進的非経口薬物送達装置販売の成長
・アジア太平洋の先進的非経口薬物送達装置販売の成長
・ヨーロッパの先進的非経口薬物送達装置販売の成長
・中東・アフリカの先進的非経口薬物送達装置販売の成長

南北アメリカ市場
・南北アメリカの国別の先進的非経口薬物送達装置販売量、売上（2018-2023）
・南北アメリカの先進的非経口薬物送達装置の種類別販売量
・南北アメリカの先進的非経口薬物送達装置の用途別販売量
・米国市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の先進的非経口薬物送達装置販売量、売上（2018-2023）
・アジア太平洋の先進的非経口薬物送達装置の種類別販売量
・アジア太平洋の先進的非経口薬物送達装置の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の先進的非経口薬物送達装置販売量、売上（2018-2023）
・ヨーロッパの先進的非経口薬物送達装置の種類別販売量
・ヨーロッパの先進的非経口薬物送達装置の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の先進的非経口薬物送達装置販売量、売上（2018-2023）
・中東・アフリカの先進的非経口薬物送達装置の種類別販売量
・中東・アフリカの先進的非経口薬物送達装置の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・先進的非経口薬物送達装置の製造コスト構造分析
・先進的非経口薬物送達装置の製造プロセス分析
・先進的非経口薬物送達装置の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・先進的非経口薬物送達装置の主要なグローバル販売業者
・先進的非経口薬物送達装置の主要なグローバル顧客

地域別の先進的非経口薬物送達装置市場予測レビュー
・地域別の先進的非経口薬物送達装置市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・先進的非経口薬物送達装置の種類別市場規模予測
・先進的非経口薬物送達装置の用途別市場規模予測

主要企業分析
Abbott Laboratories、 Amgen、 Pfizer、 Roche、 AstraZeneca、 BD、 Boston Scientific、 Bristol-Myers Squibb、 GSK、 Novartis
・企業情報
・先進的非経口薬物送達装置製品
・先進的非経口薬物送達装置販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

LPI (LP Information)’ newest research report, the “Advanced Parenteral Drug Delivery Devices Industry Forecast” looks at past sales and reviews total world Advanced Parenteral Drug Delivery Devices sales in 2022, providing a comprehensive analysis by region and market sector of projected Advanced Parenteral Drug Delivery Devices sales for 2023 through 2029. With Advanced Parenteral Drug Delivery Devices sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Advanced Parenteral Drug Delivery Devices industry.
This Insight Report provides a comprehensive analysis of the global Advanced Parenteral Drug Delivery Devices landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Advanced Parenteral Drug Delivery Devices portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Advanced Parenteral Drug Delivery Devices market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Advanced Parenteral Drug Delivery Devices and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Advanced Parenteral Drug Delivery Devices.
The global Advanced Parenteral Drug Delivery Devices market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Advanced Parenteral Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Advanced Parenteral Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Advanced Parenteral Drug Delivery Devices is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Advanced Parenteral Drug Delivery Devices players cover Abbott Laboratories, Amgen, Pfizer, Roche, AstraZeneca, BD, Boston Scientific, Bristol-Myers Squibb and GSK, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Advanced Parenteral Drug Delivery Devices market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Prefillable Syringes
IV Catheters
Vial Bag Infusion Systems
Hypodermic Syringes
Others Parenteral Delivery Devices
Segmentation by application
Hospitals
Clinics
ASCs
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Abbott Laboratories
Amgen
Pfizer
Roche
AstraZeneca
BD
Boston Scientific
Bristol-Myers Squibb
GSK
Novartis
Key Questions Addressed in this Report
What is the 10-year outlook for the global Advanced Parenteral Drug Delivery Devices market?
What factors are driving Advanced Parenteral Drug Delivery Devices market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Advanced Parenteral Drug Delivery Devices market opportunities vary by end market size?
How does Advanced Parenteral Drug Delivery Devices break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Advanced Parenteral Drug Delivery Devices Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Advanced Parenteral Drug Delivery Devices by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Advanced Parenteral Drug Delivery Devices by Country/Region, 2018, 2022 & 2029
2.2 Advanced Parenteral Drug Delivery Devices Segment by Type
2.2.1 Prefillable Syringes
2.2.2 IV Catheters
2.2.3 Vial Bag Infusion Systems
2.2.4 Hypodermic Syringes
2.2.5 Others Parenteral Delivery Devices
2.3 Advanced Parenteral Drug Delivery Devices Sales by Type
2.3.1 Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Type (2018-2023)
2.3.2 Global Advanced Parenteral Drug Delivery Devices Revenue and Market Share by Type (2018-2023)
2.3.3 Global Advanced Parenteral Drug Delivery Devices Sale Price by Type (2018-2023)
2.4 Advanced Parenteral Drug Delivery Devices Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 ASCs
2.4.4 Others
2.5 Advanced Parenteral Drug Delivery Devices Sales by Application
2.5.1 Global Advanced Parenteral Drug Delivery Devices Sale Market Share by Application (2018-2023)
2.5.2 Global Advanced Parenteral Drug Delivery Devices Revenue and Market Share by Application (2018-2023)
2.5.3 Global Advanced Parenteral Drug Delivery Devices Sale Price by Application (2018-2023)
3 Global Advanced Parenteral Drug Delivery Devices by Company
3.1 Global Advanced Parenteral Drug Delivery Devices Breakdown Data by Company
3.1.1 Global Advanced Parenteral Drug Delivery Devices Annual Sales by Company (2018-2023)
3.1.2 Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Company (2018-2023)
3.2 Global Advanced Parenteral Drug Delivery Devices Annual Revenue by Company (2018-2023)
3.2.1 Global Advanced Parenteral Drug Delivery Devices Revenue by Company (2018-2023)
3.2.2 Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Company (2018-2023)
3.3 Global Advanced Parenteral Drug Delivery Devices Sale Price by Company
3.4 Key Manufacturers Advanced Parenteral Drug Delivery Devices Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Advanced Parenteral Drug Delivery Devices Product Location Distribution
3.4.2 Players Advanced Parenteral Drug Delivery Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Advanced Parenteral Drug Delivery Devices by Geographic Region
4.1 World Historic Advanced Parenteral Drug Delivery Devices Market Size by Geographic Region (2018-2023)
4.1.1 Global Advanced Parenteral Drug Delivery Devices Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Advanced Parenteral Drug Delivery Devices Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Advanced Parenteral Drug Delivery Devices Market Size by Country/Region (2018-2023)
4.2.1 Global Advanced Parenteral Drug Delivery Devices Annual Sales by Country/Region (2018-2023)
4.2.2 Global Advanced Parenteral Drug Delivery Devices Annual Revenue by Country/Region (2018-2023)
4.3 Americas Advanced Parenteral Drug Delivery Devices Sales Growth
4.4 APAC Advanced Parenteral Drug Delivery Devices Sales Growth
4.5 Europe Advanced Parenteral Drug Delivery Devices Sales Growth
4.6 Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales Growth
5 Americas
5.1 Americas Advanced Parenteral Drug Delivery Devices Sales by Country
5.1.1 Americas Advanced Parenteral Drug Delivery Devices Sales by Country (2018-2023)
5.1.2 Americas Advanced Parenteral Drug Delivery Devices Revenue by Country (2018-2023)
5.2 Americas Advanced Parenteral Drug Delivery Devices Sales by Type
5.3 Americas Advanced Parenteral Drug Delivery Devices Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Advanced Parenteral Drug Delivery Devices Sales by Region
6.1.1 APAC Advanced Parenteral Drug Delivery Devices Sales by Region (2018-2023)
6.1.2 APAC Advanced Parenteral Drug Delivery Devices Revenue by Region (2018-2023)
6.2 APAC Advanced Parenteral Drug Delivery Devices Sales by Type
6.3 APAC Advanced Parenteral Drug Delivery Devices Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Advanced Parenteral Drug Delivery Devices by Country
7.1.1 Europe Advanced Parenteral Drug Delivery Devices Sales by Country (2018-2023)
7.1.2 Europe Advanced Parenteral Drug Delivery Devices Revenue by Country (2018-2023)
7.2 Europe Advanced Parenteral Drug Delivery Devices Sales by Type
7.3 Europe Advanced Parenteral Drug Delivery Devices Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Advanced Parenteral Drug Delivery Devices by Country
8.1.1 Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales by Country (2018-2023)
8.1.2 Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue by Country (2018-2023)
8.2 Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales by Type
8.3 Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Advanced Parenteral Drug Delivery Devices
10.3 Manufacturing Process Analysis of Advanced Parenteral Drug Delivery Devices
10.4 Industry Chain Structure of Advanced Parenteral Drug Delivery Devices
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Advanced Parenteral Drug Delivery Devices Distributors
11.3 Advanced Parenteral Drug Delivery Devices Customer
12 World Forecast Review for Advanced Parenteral Drug Delivery Devices by Geographic Region
12.1 Global Advanced Parenteral Drug Delivery Devices Market Size Forecast by Region
12.1.1 Global Advanced Parenteral Drug Delivery Devices Forecast by Region (2024-2029)
12.1.2 Global Advanced Parenteral Drug Delivery Devices Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Advanced Parenteral Drug Delivery Devices Forecast by Type
12.7 Global Advanced Parenteral Drug Delivery Devices Forecast by Application
13 Key Players Analysis
13.1 Abbott Laboratories
13.1.1 Abbott Laboratories Company Information
13.1.2 Abbott Laboratories Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.1.3 Abbott Laboratories Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Abbott Laboratories Main Business Overview
13.1.5 Abbott Laboratories Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.2.3 Amgen Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Pfizer
13.3.1 Pfizer Company Information
13.3.2 Pfizer Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.3.3 Pfizer Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Pfizer Main Business Overview
13.3.5 Pfizer Latest Developments
13.4 Roche
13.4.1 Roche Company Information
13.4.2 Roche Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.4.3 Roche Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Roche Main Business Overview
13.4.5 Roche Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.5.3 AstraZeneca Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 BD
13.6.1 BD Company Information
13.6.2 BD Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.6.3 BD Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 BD Main Business Overview
13.6.5 BD Latest Developments
13.7 Boston Scientific
13.7.1 Boston Scientific Company Information
13.7.2 Boston Scientific Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.7.3 Boston Scientific Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Boston Scientific Main Business Overview
13.7.5 Boston Scientific Latest Developments
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Information
13.8.2 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.8.3 Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bristol-Myers Squibb Main Business Overview
13.8.5 Bristol-Myers Squibb Latest Developments
13.9 GSK
13.9.1 GSK Company Information
13.9.2 GSK Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.9.3 GSK Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 GSK Main Business Overview
13.9.5 GSK Latest Developments
13.10 Novartis
13.10.1 Novartis Company Information
13.10.2 Novartis Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
13.10.3 Novartis Advanced Parenteral Drug Delivery Devices Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Novartis Main Business Overview
13.10.5 Novartis Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Advanced Parenteral Drug Delivery Devices Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Advanced Parenteral Drug Delivery Devices Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Prefillable Syringes
Table 4. Major Players of IV Catheters
Table 5. Major Players of Vial Bag Infusion Systems
Table 6. Major Players of Hypodermic Syringes
Table 7. Major Players of Others Parenteral Delivery Devices
Table 8. Global Advanced Parenteral Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 9. Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Type (2018-2023)
Table 10. Global Advanced Parenteral Drug Delivery Devices Revenue by Type (2018-2023) & ($ million)
Table 11. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Table 12. Global Advanced Parenteral Drug Delivery Devices Sale Price by Type (2018-2023) & (USD/Unit)
Table 13. Global Advanced Parenteral Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 14. Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Application (2018-2023)
Table 15. Global Advanced Parenteral Drug Delivery Devices Revenue by Application (2018-2023)
Table 16. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Application (2018-2023)
Table 17. Global Advanced Parenteral Drug Delivery Devices Sale Price by Application (2018-2023) & (USD/Unit)
Table 18. Global Advanced Parenteral Drug Delivery Devices Sales by Company (2018-2023) & (K Units)
Table 19. Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Company (2018-2023)
Table 20. Global Advanced Parenteral Drug Delivery Devices Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Company (2018-2023)
Table 22. Global Advanced Parenteral Drug Delivery Devices Sale Price by Company (2018-2023) & (USD/Unit)
Table 23. Key Manufacturers Advanced Parenteral Drug Delivery Devices Producing Area Distribution and Sales Area
Table 24. Players Advanced Parenteral Drug Delivery Devices Products Offered
Table 25. Advanced Parenteral Drug Delivery Devices Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Advanced Parenteral Drug Delivery Devices Sales by Geographic Region (2018-2023) & (K Units)
Table 29. Global Advanced Parenteral Drug Delivery Devices Sales Market Share Geographic Region (2018-2023)
Table 30. Global Advanced Parenteral Drug Delivery Devices Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Advanced Parenteral Drug Delivery Devices Sales by Country/Region (2018-2023) & (K Units)
Table 33. Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Country/Region (2018-2023)
Table 34. Global Advanced Parenteral Drug Delivery Devices Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Advanced Parenteral Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 37. Americas Advanced Parenteral Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 38. Americas Advanced Parenteral Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Advanced Parenteral Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 40. Americas Advanced Parenteral Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 41. Americas Advanced Parenteral Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 42. APAC Advanced Parenteral Drug Delivery Devices Sales by Region (2018-2023) & (K Units)
Table 43. APAC Advanced Parenteral Drug Delivery Devices Sales Market Share by Region (2018-2023)
Table 44. APAC Advanced Parenteral Drug Delivery Devices Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Advanced Parenteral Drug Delivery Devices Revenue Market Share by Region (2018-2023)
Table 46. APAC Advanced Parenteral Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 47. APAC Advanced Parenteral Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 48. Europe Advanced Parenteral Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 49. Europe Advanced Parenteral Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 50. Europe Advanced Parenteral Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Advanced Parenteral Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 52. Europe Advanced Parenteral Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 53. Europe Advanced Parenteral Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 54. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales by Country (2018-2023) & (K Units)
Table 55. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales by Type (2018-2023) & (K Units)
Table 59. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales by Application (2018-2023) & (K Units)
Table 60. Key Market Drivers & Growth Opportunities of Advanced Parenteral Drug Delivery Devices
Table 61. Key Market Challenges & Risks of Advanced Parenteral Drug Delivery Devices
Table 62. Key Industry Trends of Advanced Parenteral Drug Delivery Devices
Table 63. Advanced Parenteral Drug Delivery Devices Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Advanced Parenteral Drug Delivery Devices Distributors List
Table 66. Advanced Parenteral Drug Delivery Devices Customer List
Table 67. Global Advanced Parenteral Drug Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 68. Global Advanced Parenteral Drug Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Advanced Parenteral Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 70. Americas Advanced Parenteral Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Advanced Parenteral Drug Delivery Devices Sales Forecast by Region (2024-2029) & (K Units)
Table 72. APAC Advanced Parenteral Drug Delivery Devices Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Advanced Parenteral Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 74. Europe Advanced Parenteral Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales Forecast by Country (2024-2029) & (K Units)
Table 76. Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Advanced Parenteral Drug Delivery Devices Sales Forecast by Type (2024-2029) & (K Units)
Table 78. Global Advanced Parenteral Drug Delivery Devices Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Advanced Parenteral Drug Delivery Devices Sales Forecast by Application (2024-2029) & (K Units)
Table 80. Global Advanced Parenteral Drug Delivery Devices Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. Abbott Laboratories Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 82. Abbott Laboratories Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 83. Abbott Laboratories Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. Abbott Laboratories Main Business
Table 85. Abbott Laboratories Latest Developments
Table 86. Amgen Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 87. Amgen Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 88. Amgen Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Amgen Main Business
Table 90. Amgen Latest Developments
Table 91. Pfizer Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 92. Pfizer Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 93. Pfizer Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. Pfizer Main Business
Table 95. Pfizer Latest Developments
Table 96. Roche Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 97. Roche Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 98. Roche Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Roche Main Business
Table 100. Roche Latest Developments
Table 101. AstraZeneca Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 102. AstraZeneca Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 103. AstraZeneca Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. AstraZeneca Main Business
Table 105. AstraZeneca Latest Developments
Table 106. BD Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 107. BD Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 108. BD Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 109. BD Main Business
Table 110. BD Latest Developments
Table 111. Boston Scientific Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 112. Boston Scientific Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 113. Boston Scientific Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Boston Scientific Main Business
Table 115. Boston Scientific Latest Developments
Table 116. Bristol-Myers Squibb Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 117. Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 118. Bristol-Myers Squibb Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. Bristol-Myers Squibb Main Business
Table 120. Bristol-Myers Squibb Latest Developments
Table 121. GSK Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 122. GSK Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 123. GSK Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. GSK Main Business
Table 125. GSK Latest Developments
Table 126. Novartis Basic Information, Advanced Parenteral Drug Delivery Devices Manufacturing Base, Sales Area and Its Competitors
Table 127. Novartis Advanced Parenteral Drug Delivery Devices Product Portfolios and Specifications
Table 128. Novartis Advanced Parenteral Drug Delivery Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. Novartis Main Business
Table 130. Novartis Latest Developments
List of Figures
Figure 1. Picture of Advanced Parenteral Drug Delivery Devices
Figure 2. Advanced Parenteral Drug Delivery Devices Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Advanced Parenteral Drug Delivery Devices Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Advanced Parenteral Drug Delivery Devices Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Advanced Parenteral Drug Delivery Devices Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Prefillable Syringes
Figure 10. Product Picture of IV Catheters
Figure 11. Product Picture of Vial Bag Infusion Systems
Figure 12. Product Picture of Hypodermic Syringes
Figure 13. Product Picture of Others Parenteral Delivery Devices
Figure 14. Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Type in 2022
Figure 15. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Type (2018-2023)
Figure 16. Advanced Parenteral Drug Delivery Devices Consumed in Hospitals
Figure 17. Global Advanced Parenteral Drug Delivery Devices Market: Hospitals (2018-2023) & (K Units)
Figure 18. Advanced Parenteral Drug Delivery Devices Consumed in Clinics
Figure 19. Global Advanced Parenteral Drug Delivery Devices Market: Clinics (2018-2023) & (K Units)
Figure 20. Advanced Parenteral Drug Delivery Devices Consumed in ASCs
Figure 21. Global Advanced Parenteral Drug Delivery Devices Market: ASCs (2018-2023) & (K Units)
Figure 22. Advanced Parenteral Drug Delivery Devices Consumed in Others
Figure 23. Global Advanced Parenteral Drug Delivery Devices Market: Others (2018-2023) & (K Units)
Figure 24. Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Application (2022)
Figure 25. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Application in 2022
Figure 26. Advanced Parenteral Drug Delivery Devices Sales Market by Company in 2022 (K Units)
Figure 27. Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Company in 2022
Figure 28. Advanced Parenteral Drug Delivery Devices Revenue Market by Company in 2022 ($ Million)
Figure 29. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Company in 2022
Figure 30. Global Advanced Parenteral Drug Delivery Devices Sales Market Share by Geographic Region (2018-2023)
Figure 31. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share by Geographic Region in 2022
Figure 32. Americas Advanced Parenteral Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 33. Americas Advanced Parenteral Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 34. APAC Advanced Parenteral Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 35. APAC Advanced Parenteral Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 36. Europe Advanced Parenteral Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 37. Europe Advanced Parenteral Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 38. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales 2018-2023 (K Units)
Figure 39. Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue 2018-2023 ($ Millions)
Figure 40. Americas Advanced Parenteral Drug Delivery Devices Sales Market Share by Country in 2022
Figure 41. Americas Advanced Parenteral Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 42. Americas Advanced Parenteral Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 43. Americas Advanced Parenteral Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 44. United States Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 45. Canada Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 46. Mexico Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 47. Brazil Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 48. APAC Advanced Parenteral Drug Delivery Devices Sales Market Share by Region in 2022
Figure 49. APAC Advanced Parenteral Drug Delivery Devices Revenue Market Share by Regions in 2022
Figure 50. APAC Advanced Parenteral Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 51. APAC Advanced Parenteral Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 52. China Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 53. Japan Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 54. South Korea Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 55. Southeast Asia Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 56. India Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 57. Australia Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 58. China Taiwan Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 59. Europe Advanced Parenteral Drug Delivery Devices Sales Market Share by Country in 2022
Figure 60. Europe Advanced Parenteral Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 61. Europe Advanced Parenteral Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 62. Europe Advanced Parenteral Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 63. Germany Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 64. France Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 65. UK Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 66. Italy Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 67. Russia Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 68. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales Market Share by Country in 2022
Figure 69. Middle East & Africa Advanced Parenteral Drug Delivery Devices Revenue Market Share by Country in 2022
Figure 70. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales Market Share by Type (2018-2023)
Figure 71. Middle East & Africa Advanced Parenteral Drug Delivery Devices Sales Market Share by Application (2018-2023)
Figure 72. Egypt Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 73. South Africa Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 74. Israel Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 75. Turkey Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 76. GCC Country Advanced Parenteral Drug Delivery Devices Revenue Growth 2018-2023 ($ Millions)
Figure 77. Manufacturing Cost Structure Analysis of Advanced Parenteral Drug Delivery Devices in 2022
Figure 78. Manufacturing Process Analysis of Advanced Parenteral Drug Delivery Devices
Figure 79. Industry Chain Structure of Advanced Parenteral Drug Delivery Devices
Figure 80. Channels of Distribution
Figure 81. Global Advanced Parenteral Drug Delivery Devices Sales Market Forecast by Region (2024-2029)
Figure 82. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share Forecast by Region (2024-2029)
Figure 83. Global Advanced Parenteral Drug Delivery Devices Sales Market Share Forecast by Type (2024-2029)
Figure 84. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share Forecast by Type (2024-2029)
Figure 85. Global Advanced Parenteral Drug Delivery Devices Sales Market Share Forecast by Application (2024-2029)
Figure 86. Global Advanced Parenteral Drug Delivery Devices Revenue Market Share Forecast by Application (2024-2029)

※参考情報

先進的非経口薬物送達装置は、医薬品を体内へ直接送達するための高度なシステムであり、主に注射や点滴などの経路を通じて使用されます。従来の経口投与と比較して、非経口薬物送達は多くの利点を提供します。これにより、医療現場における患者の治療の質が向上し、治療効果を最大限に引き出すことが可能となります。

これらの装置は、患者のニーズや治療の特性に応じて設計されており、さまざまなタイプや機能を持っています。通常、先進的な非経口薬物送達装置は、薬物が迅速かつ正確に体内に届けられることを目的としています。これには、薬物の安定性を保ちながら、効果的に作用させるための技術が組み合わさっています。これにより、患者はより少ない副作用で治療を受けることができ、治療の継続性も高まります。

先進的非経口薬物送達装置の特徴として、まず第一に、その精度と効率性が挙げられます。これには、薬物の放出を制御するための技術が含まれています。多くの装置は、薬物の濃度をリアルタイムでモニタリングし、必要に応じて自動的に投与量を調整することが可能です。これにより、患者は一定の薬物濃度を保持でき、治療効果が持続します。また、患者の生活の質を向上させるために、使いやすさや快適さも考慮されており、痛みの少ない投与方法が模索されています。

装置の種類としては、インスリンポンプやポータブル点滴装置、経皮的な薬物送達システムなどがあります。インスリンポンプは主に糖尿病患者に使用され、必要に応じてインスリンを自動的に供給します。これにより、血糖コントロールの向上が期待されます。ポータブル点滴装置は、入院患者だけでなく、在宅での治療にも対応しており、患者が自宅で治療を続けやすくなります。また、経皮的薬物送達システムは、皮膚を介して薬物を送達する方法で、気管支喘息や痛みの管理に使用されます。

さらに、先進的な薬物送達装置には、マイクロニードルやナノ粒子技術などの関連技術が組み合わさることが多いです。マイクロニードルは、皮膚を傷つけることなく薬物を浸透させるための小さな針であり、痛みを軽減しながら、迅速な吸収を可能にします。ナノ粒子技術は、薬物をナノサイズの粒子に分解することで、より効率的な送達を実現します。これらの技術は、新しい薬物の開発や特定の標的組織に薬物を届けるための基盤となり、医療の革新を促進します。

用途としては、がん治療、自身免疫疾患、慢性疾患管理など、多岐にわたります。がん治療においては、腫瘍に局所的に作用する薬物送達システムが注目されています。また、自己免疫疾患や慢性疾患の治療では、長期間安定した薬物濃度を維持できる装置が重宝されています。これにより、患者のQOLが向上し、治療の持続可能性が高まります。

先進的非経口薬物送達装置の発展には、さまざまな研究と技術革新が寄与しています。例えば、AI（人工知能）を活用したデータ分析により、個々の患者の治療効果を向上させるモデルが開発されるなど、デジタル技術と医療の統合が進んでいます。また、治療方法の個別化が進む中で、患者一人ひとりのニーズに応じたカスタマイズ可能な装置の必要性が高まっています。

加えて、規制や倫理的な観点も重要です。新しい薬物送達技術が市場に出る際には、効果と安全性が厳密に評価される必要があります。このようなプロセスは、患者が安心して治療を受けるために必要不可欠です。

先進的非経口薬物送達装置は今後も進化を遂げるでしょう。テクノロジーの進展に伴い、より効率的で患者に優しい装置が登場し、医療の在り方を変えていくことが期待されます。これにより、様々な疾患に対する治療がより効果的に行えるようになることでしょう。最終的には、これらの技術が患者の生活の質をより良くし、医療全体の効率化に寄与することを願っています。


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 先進的非経口薬物送達装置のグローバル市場予測2023-2029(Global Advanced Parenteral Drug Delivery Devices Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 先進的非経口薬物送達のグローバル市場予測2023-2029
  • 自己免疫疾患用薬物送達装置のグローバル市場予測2023-2029
  • 先進型薬物送達装置の世界市場2023年～2030年：種類別、用途別、技術別、地域別
  • バイオ医薬品におけるドラッグ・デリバリーデバイスの世界市場見通し2023年-2029年
  • 世界の薬物送達デバイス市場（2023-2030）：投与経路別（注射、局所、眼、その他）、用途別（癌、循環器、糖尿病、感染症、その他）、エンドユーザー別（病院、外来手術センター、その他）、地域別

    • ◆H&Iグローバルリサーチのお客様（例）◆